Global Oncology Injection Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Oncology Injection Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Oncology Injection Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Oncology Injection Drug by Country/Region, 2017, 2022 & 2028

2.2 Oncology Injection Drug Segment by Type

2.2.1 Organs

2.2.2 Central Nervous System

2.2.3 Circulatory/Musculoskeletal System

2.2.4 Other

2.3 Oncology Injection Drug Sales by Type

2.3.1 Global Oncology Injection Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Oncology Injection Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Oncology Injection Drug Sale Price by Type (2017-2022)

2.4 Oncology Injection Drug Segment by Application

2.4.1 Lymphoma

2.4.2 Myeloma

2.4.3 Prostate Cancer

2.4.4 Other

2.5 Oncology Injection Drug Sales by Application

2.5.1 Global Oncology Injection Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Oncology Injection Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Oncology Injection Drug Sale Price by Application (2017-2022)

3 Global Oncology Injection Drug by Company

3.1 Global Oncology Injection Drug Breakdown Data by Company

3.1.1 Global Oncology Injection Drug Annual Sales by Company (2020-2022)

3.1.2 Global Oncology Injection Drug Sales Market Share by Company (2020-2022)

3.2 Global Oncology Injection Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Oncology Injection Drug Revenue by Company (2020-2022)

3.2.2 Global Oncology Injection Drug Revenue Market Share by Company (2020-2022)

3.3 Global Oncology Injection Drug Sale Price by Company

3.4 Key Manufacturers Oncology Injection Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Oncology Injection Drug Product Location Distribution

3.4.2 Players Oncology Injection Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Oncology Injection Drug by Geographic Region

4.1 World Historic Oncology Injection Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Oncology Injection Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Oncology Injection Drug Annual Revenue by Geographic Region

4.2 World Historic Oncology Injection Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Oncology Injection Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Oncology Injection Drug Annual Revenue by Country/Region

4.3 Americas Oncology Injection Drug Sales Growth

4.4 APAC Oncology Injection Drug Sales Growth

4.5 Europe Oncology Injection Drug Sales Growth

4.6 Middle East & Africa Oncology Injection Drug Sales Growth

5 Americas

5.1 Americas Oncology Injection Drug Sales by Country

5.1.1 Americas Oncology Injection Drug Sales by Country (2017-2022)

5.1.2 Americas Oncology Injection Drug Revenue by Country (2017-2022)

5.2 Americas Oncology Injection Drug Sales by Type

5.3 Americas Oncology Injection Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Oncology Injection Drug Sales by Region

6.1.1 APAC Oncology Injection Drug Sales by Region (2017-2022)

6.1.2 APAC Oncology Injection Drug Revenue by Region (2017-2022)

6.2 APAC Oncology Injection Drug Sales by Type

6.3 APAC Oncology Injection Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Oncology Injection Drug by Country

7.1.1 Europe Oncology Injection Drug Sales by Country (2017-2022)

7.1.2 Europe Oncology Injection Drug Revenue by Country (2017-2022)

7.2 Europe Oncology Injection Drug Sales by Type

7.3 Europe Oncology Injection Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Oncology Injection Drug by Country

8.1.1 Middle East & Africa Oncology Injection Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Oncology Injection Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Oncology Injection Drug Sales by Type

8.3 Middle East & Africa Oncology Injection Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Oncology Injection Drug

10.3 Manufacturing Process Analysis of Oncology Injection Drug

10.4 Industry Chain Structure of Oncology Injection Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Oncology Injection Drug Distributors

11.3 Oncology Injection Drug Customer

12 World Forecast Review for Oncology Injection Drug by Geographic Region

12.1 Global Oncology Injection Drug Market Size Forecast by Region

12.1.1 Global Oncology Injection Drug Forecast by Region (2023-2028)

12.1.2 Global Oncology Injection Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Oncology Injection Drug Forecast by Type

12.7 Global Oncology Injection Drug Forecast by Application

13 Key Players Analysis

13.1 Taj Oncology

13.1.1 Taj Oncology Company Information

13.1.2 Taj Oncology Oncology Injection Drug Product Offered

13.1.3 Taj Oncology Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Taj Oncology Main Business Overview

13.1.5 Taj Oncology Latest Developments

13.2 S.G. Biopharm

13.2.1 S.G. Biopharm Company Information

13.2.2 S.G. Biopharm Oncology Injection Drug Product Offered

13.2.3 S.G. Biopharm Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 S.G. Biopharm Main Business Overview

13.2.5 S.G. Biopharm Latest Developments

13.3 AdvaCare

13.3.1 AdvaCare Company Information

13.3.2 AdvaCare Oncology Injection Drug Product Offered

13.3.3 AdvaCare Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 AdvaCare Main Business Overview

13.3.5 AdvaCare Latest Developments

13.4 Merrimack

13.4.1 Merrimack Company Information

13.4.2 Merrimack Oncology Injection Drug Product Offered

13.4.3 Merrimack Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Merrimack Main Business Overview

13.4.5 Merrimack Latest Developments

13.5 Celgene

13.5.1 Celgene Company Information

13.5.2 Celgene Oncology Injection Drug Product Offered

13.5.3 Celgene Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Celgene Main Business Overview

13.5.5 Celgene Latest Developments

13.6 Allos Therapeutics

13.6.1 Allos Therapeutics Company Information

13.6.2 Allos Therapeutics Oncology Injection Drug Product Offered

13.6.3 Allos Therapeutics Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Allos Therapeutics Main Business Overview

13.6.5 Allos Therapeutics Latest Developments

13.7 Ferring Pharmaceuticals

13.7.1 Ferring Pharmaceuticals Company Information

13.7.2 Ferring Pharmaceuticals Oncology Injection Drug Product Offered

13.7.3 Ferring Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Ferring Pharmaceuticals Main Business Overview

13.7.5 Ferring Pharmaceuticals Latest Developments

13.8 Genzyme

13.8.1 Genzyme Company Information

13.8.2 Genzyme Oncology Injection Drug Product Offered

13.8.3 Genzyme Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Genzyme Main Business Overview

13.8.5 Genzyme Latest Developments

13.9 Eli Lilly

13.9.1 Eli Lilly Company Information

13.9.2 Eli Lilly Oncology Injection Drug Product Offered

13.9.3 Eli Lilly Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Eli Lilly Main Business Overview

13.9.5 Eli Lilly Latest Developments

13.10 Praecis Pharmaceuticals

13.10.1 Praecis Pharmaceuticals Company Information

13.10.2 Praecis Pharmaceuticals Oncology Injection Drug Product Offered

13.10.3 Praecis Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Praecis Pharmaceuticals Main Business Overview

13.10.5 Praecis Pharmaceuticals Latest Developments

13.11 Millennium Pharmaceuticals

13.11.1 Millennium Pharmaceuticals Company Information

13.11.2 Millennium Pharmaceuticals Oncology Injection Drug Product Offered

13.11.3 Millennium Pharmaceuticals Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Millennium Pharmaceuticals Main Business Overview

13.11.5 Millennium Pharmaceuticals Latest Developments

13.12 Debiopharm

13.12.1 Debiopharm Company Information

13.12.2 Debiopharm Oncology Injection Drug Product Offered

13.12.3 Debiopharm Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Debiopharm Main Business Overview

13.12.5 Debiopharm Latest Developments

13.13 Alza

13.13.1 Alza Company Information

13.13.2 Alza Oncology Injection Drug Product Offered

13.13.3 Alza Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Alza Main Business Overview

13.13.5 Alza Latest Developments

13.14 CordenPharma

13.14.1 CordenPharma Company Information

13.14.2 CordenPharma Oncology Injection Drug Product Offered

13.14.3 CordenPharma Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 CordenPharma Main Business Overview

13.14.5 CordenPharma Latest Developments

13.15 Pharmascience

13.15.1 Pharmascience Company Information

13.15.2 Pharmascience Oncology Injection Drug Product Offered

13.15.3 Pharmascience Oncology Injection Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Pharmascience Main Business Overview

13.15.5 Pharmascience Latest Developments

14 Research Findings and Conclusion

Table 1. Oncology Injection Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Oncology Injection Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Organs

Table 4. Major Players of Central Nervous System

Table 5. Major Players of Circulatory/Musculoskeletal System

Table 6. Major Players of Other

Table 7. Global Oncology Injection Drug Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Oncology Injection Drug Sales Market Share by Type (2017-2022)

Table 9. Global Oncology Injection Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Oncology Injection Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Oncology Injection Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Oncology Injection Drug Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Oncology Injection Drug Sales Market Share by Application (2017-2022)

Table 14. Global Oncology Injection Drug Revenue by Application (2017-2022)

Table 15. Global Oncology Injection Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Oncology Injection Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Oncology Injection Drug Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Oncology Injection Drug Sales Market Share by Company (2020-2022)

Table 19. Global Oncology Injection Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Oncology Injection Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Oncology Injection Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Oncology Injection Drug Producing Area Distribution and Sales Area

Table 23. Players Oncology Injection Drug Products Offered

Table 24. Oncology Injection Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Oncology Injection Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Oncology Injection Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Oncology Injection Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Oncology Injection Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Oncology Injection Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Oncology Injection Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Oncology Injection Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Oncology Injection Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Oncology Injection Drug Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Oncology Injection Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Oncology Injection Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Oncology Injection Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Oncology Injection Drug Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Oncology Injection Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Oncology Injection Drug Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Oncology Injection Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Oncology Injection Drug Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Oncology Injection Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Oncology Injection Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Oncology Injection Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Oncology Injection Drug Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Oncology Injection Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Oncology Injection Drug Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Oncology Injection Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Oncology Injection Drug Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Oncology Injection Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Oncology Injection Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Oncology Injection Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Oncology Injection Drug Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Oncology Injection Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Oncology Injection Drug Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Oncology Injection Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Oncology Injection Drug Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Oncology Injection Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Oncology Injection Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Oncology Injection Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Oncology Injection Drug Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Oncology Injection Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Oncology Injection Drug Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Oncology Injection Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Oncology Injection Drug

Table 68. Key Market Challenges & Risks of Oncology Injection Drug

Table 69. Key Industry Trends of Oncology Injection Drug

Table 70. Oncology Injection Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Oncology Injection Drug Distributors List

Table 73. Oncology Injection Drug Customer List

Table 74. Global Oncology Injection Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Oncology Injection Drug Sales Market Forecast by Region

Table 76. Global Oncology Injection Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Oncology Injection Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Oncology Injection Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Oncology Injection Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Oncology Injection Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Oncology Injection Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Oncology Injection Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Oncology Injection Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Oncology Injection Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Oncology Injection Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Oncology Injection Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Oncology Injection Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Oncology Injection Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Oncology Injection Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Oncology Injection Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Oncology Injection Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Oncology Injection Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Oncology Injection Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. Taj Oncology Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Taj Oncology Oncology Injection Drug Product Offered

Table 96. Taj Oncology Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. Taj Oncology Main Business

Table 98. Taj Oncology Latest Developments

Table 99. S.G. Biopharm Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. S.G. Biopharm Oncology Injection Drug Product Offered

Table 101. S.G. Biopharm Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. S.G. Biopharm Main Business

Table 103. S.G. Biopharm Latest Developments

Table 104. AdvaCare Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. AdvaCare Oncology Injection Drug Product Offered

Table 106. AdvaCare Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. AdvaCare Main Business

Table 108. AdvaCare Latest Developments

Table 109. Merrimack Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. Merrimack Oncology Injection Drug Product Offered

Table 111. Merrimack Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. Merrimack Main Business

Table 113. Merrimack Latest Developments

Table 114. Celgene Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. Celgene Oncology Injection Drug Product Offered

Table 116. Celgene Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. Celgene Main Business

Table 118. Celgene Latest Developments

Table 119. Allos Therapeutics Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 120. Allos Therapeutics Oncology Injection Drug Product Offered

Table 121. Allos Therapeutics Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 122. Allos Therapeutics Main Business

Table 123. Allos Therapeutics Latest Developments

Table 124. Ferring Pharmaceuticals Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 125. Ferring Pharmaceuticals Oncology Injection Drug Product Offered

Table 126. Ferring Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 127. Ferring Pharmaceuticals Main Business

Table 128. Ferring Pharmaceuticals Latest Developments

Table 129. Genzyme Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 130. Genzyme Oncology Injection Drug Product Offered

Table 131. Genzyme Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 132. Genzyme Main Business

Table 133. Genzyme Latest Developments

Table 134. Eli Lilly Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 135. Eli Lilly Oncology Injection Drug Product Offered

Table 136. Eli Lilly Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 137. Eli Lilly Main Business

Table 138. Eli Lilly Latest Developments

Table 139. Praecis Pharmaceuticals Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 140. Praecis Pharmaceuticals Oncology Injection Drug Product Offered

Table 141. Praecis Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 142. Praecis Pharmaceuticals Main Business

Table 143. Praecis Pharmaceuticals Latest Developments

Table 144. Millennium Pharmaceuticals Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 145. Millennium Pharmaceuticals Oncology Injection Drug Product Offered

Table 146. Millennium Pharmaceuticals Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 147. Millennium Pharmaceuticals Main Business

Table 148. Millennium Pharmaceuticals Latest Developments

Table 149. Debiopharm Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 150. Debiopharm Oncology Injection Drug Product Offered

Table 151. Debiopharm Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 152. Debiopharm Main Business

Table 153. Debiopharm Latest Developments

Table 154. Alza Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 155. Alza Oncology Injection Drug Product Offered

Table 156. Alza Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 157. Alza Main Business

Table 158. Alza Latest Developments

Table 159. CordenPharma Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 160. CordenPharma Oncology Injection Drug Product Offered

Table 161. CordenPharma Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 162. CordenPharma Main Business

Table 163. CordenPharma Latest Developments

Table 164. Pharmascience Basic Information, Oncology Injection Drug Manufacturing Base, Sales Area and Its Competitors

Table 165. Pharmascience Oncology Injection Drug Product Offered

Table 166. Pharmascience Oncology Injection Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 167. Pharmascience Main Business

Table 168. Pharmascience Latest Developments

List of Figures

Figure 1. Picture of Oncology Injection Drug

Figure 2. Oncology Injection Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Oncology Injection Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Oncology Injection Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Oncology Injection Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Organs

Figure 10. Product Picture of Central Nervous System

Figure 11. Product Picture of Circulatory/Musculoskeletal System

Figure 12. Product Picture of Other

Figure 13. Global Oncology Injection Drug Sales Market Share by Type in 2021

Figure 14. Global Oncology Injection Drug Revenue Market Share by Type (2017-2022)

Figure 15. Oncology Injection Drug Consumed in Lymphoma

Figure 16. Global Oncology Injection Drug Market: Lymphoma (2017-2022) & (K Pcs)

Figure 17. Oncology Injection Drug Consumed in Myeloma

Figure 18. Global Oncology Injection Drug Market: Myeloma (2017-2022) & (K Pcs)

Figure 19. Oncology Injection Drug Consumed in Prostate Cancer

Figure 20. Global Oncology Injection Drug Market: Prostate Cancer (2017-2022) & (K Pcs)

Figure 21. Oncology Injection Drug Consumed in Other

Figure 22. Global Oncology Injection Drug Market: Other (2017-2022) & (K Pcs)

Figure 23. Global Oncology Injection Drug Sales Market Share by Application (2017-2022)

Figure 24. Global Oncology Injection Drug Revenue Market Share by Application in 2021

Figure 25. Oncology Injection Drug Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Oncology Injection Drug Revenue Market Share by Company in 2021

Figure 27. Global Oncology Injection Drug Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Oncology Injection Drug Revenue Market Share by Geographic Region in 2021

Figure 29. Global Oncology Injection Drug Sales Market Share by Region (2017-2022)

Figure 30. Global Oncology Injection Drug Revenue Market Share by Country/Region in 2021

Figure 31. Americas Oncology Injection Drug Sales 2017-2022 (K Pcs)

Figure 32. Americas Oncology Injection Drug Revenue 2017-2022 ($ Millions)

Figure 33. APAC Oncology Injection Drug Sales 2017-2022 (K Pcs)

Figure 34. APAC Oncology Injection Drug Revenue 2017-2022 ($ Millions)

Figure 35. Europe Oncology Injection Drug Sales 2017-2022 (K Pcs)

Figure 36. Europe Oncology Injection Drug Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Oncology Injection Drug Sales 2017-2022 (K Pcs)

Figure 38. Middle East & Africa Oncology Injection Drug Revenue 2017-2022 ($ Millions)

Figure 39. Americas Oncology Injection Drug Sales Market Share by Country in 2021

Figure 40. Americas Oncology Injection Drug Revenue Market Share by Country in 2021

Figure 41. United States Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Oncology Injection Drug Sales Market Share by Region in 2021

Figure 46. APAC Oncology Injection Drug Revenue Market Share by Regions in 2021

Figure 47. China Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Oncology Injection Drug Sales Market Share by Country in 2021

Figure 54. Europe Oncology Injection Drug Revenue Market Share by Country in 2021

Figure 55. Germany Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Oncology Injection Drug Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Oncology Injection Drug Revenue Market Share by Country in 2021

Figure 62. Egypt Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Oncology Injection Drug Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Oncology Injection Drug in 2021

Figure 68. Manufacturing Process Analysis of Oncology Injection Drug

Figure 69. Industry Chain Structure of Oncology Injection Drug

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles